A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...

AMSBIO announces the launch of mRNA-In™ and mRNA-In™ Neuro – a new range of high efficiency, targeted transfection reagents. Offering high transfection efficiency and expression levels across a broad ...

This was in addition to the $176 million awarded by the US Department of Health and Human Services (HHS) last year to complete the late-stage development and testing of a pre-pandemic mRNA-based ...

Researchers develop innovative phospholipids that improve the functional delivery of mRNA via lipid nanoparticles, paving the ...

MRNA technology is facing growing doubts among Republicans. This is a KFF Health News story. Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology ...

Vaccine skeptics have long-since leveraged the rapid roll out of mRNA vaccines to add fuel to heated arguments surrounding vaccine safety. As a result, a growing share of the public is wary of ...

Problem: siRNA might depress mRNA levels but not induce the expected phenotype. Controls: Looking for a decrease in levels of your targeted mRNA isn't enough, Rozenfeld says; you should also look for ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

Scientists at Yale University are investigating a mysterious condition linked to mRNA Covid vaccines. Many people have reported unusual symptoms after vaccination, but identifying rare side ...

Vaccines using messenger RNA, or mRNA, technology became widespread during the pandemic. With limited long-term studies available, the Trump administration is revisiting these vaccines.